NYSEAM:SENS - Post Discussion
Post by
whytestocks on Mar 08, 2024 3:30pm
Senseonics Holdings, Inc. Announces Data From the Eversense&
Breaking News: $SENS Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesSenseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced data from the Eversense ® Post Approval Study is to b...
SENS - Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Be the first to comment on this post